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This is the third installment in a series of 
editorials on the implications of open-access 
publishing for established publishing practices and 
stakeholders in scientiﬁ  c and medical research.
T
he questions, tensions, and 
social concerns surrounding 
copyright and the Internet are 
very different for scientiﬁ  c and medical 
literature than for other kinds of 
easily reproducible digital works. Peer-
reviewed publications are often the sole 
tangible products of the tremendously 
time-consuming and expensive process 
of conducting primary research in 
biology and medicine. Who should 
own the primary research articles 
that are the culmination of years 
of work by scientists and staggering 
ﬁ  nancial investments by governments, 
universities, and tax-exempt 
foundations? What uses should the 
documents’ owners permit?
In practice, academic authors 
typically assign full copyrights to 
their articles to the publishers of the 
journals in which the works appear. 
Scientists do not beneﬁ  t ﬁ  nancially 
from the transaction; indeed, they 
often subsidize the cost of their 
articles’ publication in the form of 
page charges, color charges, and 
other fees levied by publishers. The 
prestige associated with publishing in a 
selective journal is sufﬁ  ciently valuable 
that scientists are generally willing to 
abdicate the legal rights to their own 
work without remuneration.
In recent years, however, several 
technological and legal innovations 
have led a growing number of scientists 
to begin to question the sagacity of 
this arrangement. The advent of 
electronic publishing and the Internet 
itself have made technically possible a 
slew of novel uses of primary research 
papers. Simultaneously, the traditional 
“all rights reserved” copyright license 
has been supplemented by a variety 
of alternative licenses—of equal legal 
validity and available at no charge to 
anyone who wants them—that allow 
copyright holders to prevent some 
uses of a work without permission, 
but to authorize others. Different 
licenses created by the nonproﬁ  t 
organization Creative Commons 
(www.creativecommons.org), for 
example, allow copyright holders to 
mark their work with freedoms—to 
permit a work’s reproduction for 
any noncommercial purpose (the 
Noncommercial License) or for 
any purpose at all provided that 
the original authorship is properly 
attributed (the Attribution License).
The upshot of these developments 
is that copyright holders can now 
permit a spectrum of uses of a paper by 
prospective researchers, anthologizers, 
archivists, teachers, patients,  policy 
makers, journalists, and other 
interested parties. Precisely which uses 
are permitted and which are not is far 
from a trivial matter. The particular 
copyright license under which an 
article is published largely determines 
how the document can be stored, 
searched, and built upon by other 
scientists. 
Authors’ Rights and Users’ Rights
One implication of the variety of 
copyright licenses now widely available 
is that the right to use an article in one 
way or another is largely independent 
of its accessibility online. A paper that 
is touted as “freely available” or “free 
access” is very different from one that 
is “open access.” (See http:⁄⁄www.
plos.org/openaccess for the formal 
deﬁ  nition of an open-access article, 
drafted at the 11 April 2003 Bethesda 
Meeting on Open Access Publishing.) 
When a document is “freely available,” 
someone who comes across it may be 
permitted to do nothing more than 
read it online on a publisher’s Web 
site; the right to use the article in any 
other way is typically granted only at 
the publisher’s discretion. When a 
document is open access, however, 
a wide range of additional uses are 
perpetually and irrevocably allowed—
from the reproduction and distribution 
of the paper by a professor for his or 
her students to the archiving of the 
paper in a searchable online repository 
available to anyone in the world with an 
Internet connection, and more. 
The Creative Commons Attribution 
License (CCAL), which governs this 
editorial and all other content in PLoS 
Biology, permits a number of uses of 
articles that are typically restricted 
and for which there is an immediate 
demand. All articles published by PLoS 
can be included in coursepacks—a 
use-right that most authors would 
want to allow without exception, but 
that most traditional publishers grant 
only for a substantial fee (which they 
rarely share with authors). The CCAL 
also ensures that institutions are 
permitted to archive not only articles 
written by their own faculty, but all 
other works published under the same 
legal terms as well, thereby facilitating 
their permanent accessibility and 
preservation. For example, the 
LOCKSS (“Lots of Copies Keep Stuff 
Safe”) program (http:⁄⁄lockss.stanford.
edu/projectdescbrief.htm), an ongoing 
project to support libraries’ efforts to 
“create, preserve, and archive local 
electronic collections,” is viable only 
insofar as institutions are permitted to 
store information themselves, rather 
than access it exclusively via publishers’ 
Web sites. Many collaborative projects 
between libraries and publishers have 
been complicated by legal constraints, 
including the stipulation that archives 
remain “dark,” or inaccessible to 
users, until any commercial incentive 
for restricting access to articles has 
been exhausted—clearly a suboptimal 
arrangement for researchers, and one 
that is unnecessary for collections of 
works governed by the CCAL. 
One of the truly revolutionary 
implications of open-access articles, 
however, is that we simply do not 
know the full range of their potential 
applications. They are available for any 
use that any entrepreneur can envision, 
so long as the authors of the papers are 
properly credited. The only certainty, 
then, is that the utility of open-access 
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research articles will be limited solely 
by the imagination of those that are 
inspired by the possibilities—rather 
than by legal constraints. 
Authors’ Protections
Authors retain the copyright to all 
articles in PLoS Biology and license 
their works under nonexclusive terms 
that reserve only some—rather than 
all—rights. There are several common 
objections, generally leveled by 
publishers, against this practice. For 
example, it is sometimes argued that 
the traditional copyright arrangement 
in scientiﬁ  c publishing protects against 
uses of articles that authors would 
object to—while the CCAL permits 
such uses and renders authors helpless 
to prevent them. 
To the extent that the uses in 
question are for academic or archival 
purposes, such as those discussed 
above, it is certainly true that the 
CCAL permits practices that “all rights 
reserved” licenses do not. Indeed, the 
expanded range of legitimate academic 
uses of articles is among the primary 
selling points of the CCAL in the 
context of scientiﬁ  c publishing. To the 
extent that the ostensibly objectionable 
uses are commercial, the problem 
is easily remedied with the Creative 
Commons Noncommercial License, 
which prohibits commercial reuse of 
a work without the copyright holder’s 
consent. 
PLoS has chosen, for reasons both 
philosophical and pragmatic, to 
permit the commercial use of works 
we publish. As a matter of principle, 
all of our policies reﬂ  ect the view 
that scientiﬁ  c publishers are service 
providers and should not themselves 
restrict the potential applications of 
the largely publicly funded work in 
their journals. More concretely, if a 
commercial enterprise is interested in 
repackaging the articles that PLoS has 
published, we are loath to prevent an 
author’s work from wider distribution. 
Any risk that a company will use an 
article for a purpose its author would 
be uncomfortable with is, in our view, 
substantially outweighed by the beneﬁ  ts 
of allowing—not on a case-by-case basis, 
but across the board—the reproduction 
of the article for inclusion in online 
encyclopedias, or for distribution in 
countries in which Internet access is 
unreliable, or, indeed, for creative uses 
we hope to inspire by making primary 
research articles legally available to 
commercial interests.
Another recurring objection to 
the copyright arrangement that 
PLoS employs is that authors are 
inappropriate copyright holders 
because they are ill-equipped to protect 
their own works against plagiarism, 
misattribution, and other misuse. 
Most scientists, however, have enough 
familiarity with cases of plagiarism 
in their own ﬁ  eld to know that their 
strongest protection against mis- or 
nonattribution is derived not from the 
threat of prosecution for copyright 
infringement, but from community 
standards of conduct. Furthermore, 
among the beneﬁ  ts of open-access 
articles is the fact that their full texts, 
rather than just their abstracts, are 
searchable—which, as any teacher 
knows, makes plagiarism much easier 
to detect. 
Beyond plagiarism and 
misattribution, it is not clear what uses 
of primary research articles authors 
would actually want to prevent (other 
than, perhaps, the commercial uses 
that their work is already susceptible to, 
in many cases, when publishers hold 
copyrights). Scientists do not receive 
royalties for their published work. The 
more widely their articles are read 
and cited, the more their professional 
reputations are bolstered. Certainly, 
research articles have a wide range of 
uses that publishers typically object to—
and indeed often ﬁ  le suit over—such 
as their compilation in coursepacks 
by copy shops. Those applications, 
however, tend not to constitute 
“misuse” in many authors’ eyes. 
Authors’ Voice
There is no question that the 
licensing arrangement PLoS employs 
is relatively novel—and therefore 
untested over the long term—in 
biomedical publishing. However, it 
hardly takes a radical understanding 
of the interests of authors and users of 
primary research articles to conclude 
that the open-access terms of copyright 
promise substantial beneﬁ  ts for both 
groups. 
What, then, can scientists do 
to encourage other publishers to 
follow suit and strike similar legal 
arrangements with authors as a 
matter of course? One answer is to 
“vote with your submissions;” that 
is, authors should submit their work 
preferentially to journals with copyright 
and licensing practices that genuinely 
serve their interests. Another equally 
important action for scientists is to 
raise the issue with their professional 
societies. Scholarly associations exist, 
among other reasons, to serve the 
needs of their members—and society 
members should actively urge their 
society journals to employ the CCAL 
or a similar license for their research 
articles.
Scientiﬁ  c and medical literature is 
different from ﬁ  ction or movies or 
music. The United States government 
invests more than $28 billion per year 
in the National Institutes of Health 
alone to fund research in biology and 
medicine. The scientists who conduct 
that research and the research paid 
for by other public-minded institutions 
in the United States and abroad have 
an afﬁ  rmative moral obligation to 
share the knowledge they create—not 
just with students and faculty at elite 
Western universities, but with everyone 
who could use it and build upon it. 
When authors publish their work in 
journals with restrictive copyright 
practices, it becomes illegal (often 
for even the authors themselves) to 
store primary research articles in 
many archives or include them in 
coursepacks or use them for other 
responsible purposes. Those obstacles 
to sharing knowledge can be avoided 
without legislative intervention, 
however, if scientists and publishers 
alike embrace a legal paradigm for 
disseminating new discoveries that 
maximizes their utility.  